chrisvoncsefalvay/vaers-outcomes huggingface dataset:
flu like sypmtoms; tested positive for COVID; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (tested positive for COVID) and INFLUENZA LIKE ILLNESS (flu like sypmtoms) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer. Concomitant products included ANASTROZOLE (ARIMIDEX) for Breast cancer.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced COVID-19 (tested positive for COVID). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like sypmtoms). At the time of the report, COVID-19 (tested positive for COVID) and INFLUENZA LIKE ILLNESS (flu like sypmtoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2021, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 20-Sep-2021: Non-significant follow up- Reporter info. updated
Very sore arm, 102 fever, body aches, nausea, lethargy
High fever at night (up to 103.9) persisting from January 30 until present, night sweats, chills.  Lower fever during the day (100- 101.4)
Woke up screaming could not comfort, would stop breathing few seconds then resume breathing; Parents called MD who advised meeting them @ Hosp ER; By time seen by MD pt sx had cleared @ 1130PM;
Information has been received from a physician concerning an approx. 19 year old female who was vaccinated with MMRII (lot 635919/0014L) (diluent lot 638152/1779K). Subsequently, the pt experienced severe rhinorrhea, runny and swollen eyes, wheezing and urticaria on her trunk and limbs, about 20 minutes, post vax. She was treated with IM diphenhydramine hydrochloride (Benadryl). Another pt (WAES 01092376) had a similar experience, post vax, with MMRII same lot and diluent numbers. It was noted that the reporter is "uncomfortable using MMR from the same lot". Upon internal review, the pt's experience was considered an "Other Important Medical Event". Additional information has been requested. F/U has been received from a healthcare professioanl indicating that the pt recoverd. She also reported that she did not think the student was positive on her allergies. The records of testing prior to release of this not have been checked and found to be satisfactory. The lot complies with the normal standards of the Center for Biologics Evaluation and Research and was released.
cough; chronic diarrhea/Uncontrollable Diarrhea; Itching on back of my head and in front of my arms; hands and muscles aching; swelling; pain; hands and muscles aching; This is a spontaneous report from a contactable reported for unknown patient. A 58-year-old female patient received BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 07Apr2021, as dose 2, single for COVID-19 immunization. The patient's medical history included hearing impairment and smoker, unknown if ongoing. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On an unspecified date, after the second dose of vaccine, the patient experienced cough; but attributed it to smoking, chronic diarrhoea/uncontrollable diarrhoea, itching on back of her head and in front of her arms, hands and muscles aching, swelling, and pain. Patient experienced chronic uncontrollable diarrhoea and every time when she ate or drink something, she had diarrhea afterwards. The patient took Pepto-Bismol for diarrhoea and it did not stop. She tried to eat fruits and everything but became miserable. The clinical outcome of the event diarrhoea was not resolved and clinical outcome of all other events was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.
Following vaccines on 6/16/2017 patient began throwing up his milk and wouldn't tolerate any solid foods. He began showing signs of speech delay, heavily wetting his diapers, irritabiltity and was misdiagnosed with GERD.   He began showing s/s of type 1 diabetes right after his vaccinations and was misdiagnosed until 9/10/2017 while in DKA.
Patient stated his throat was getting scratchy and tight, red blotchy rash noted to upper torso and arms. Admitted patient to ER. Given IV meds.
I tested positive for COVID; I became ill the following day Friday through Sunday; This is a spontaneous report received from a contactable consumer(patient) via medical information team. A female patient of unspecified age received first dose of (BNT162B2) (solution for injection/Lot/Batch number unknown), via unspecified route of administration on 25Feb2021 at a single dose for COVID-19 immunization. The patient's Medical history and concomitant medications were not reported. On an unspecified date the patient became ill, tested COVID positive and was admitted to the hospital on 06Mar2021. She was released and came home. While in the ER, they gave plasma and told that she won't be able to get the Pfizer vaccine in 90 days. There's nothing on the CDC that addresses this patient has stated that Efficacy in Participants 16 Years of Age and Older" regarding exclusion of participants with a previous clinical or microbiological diagnosis of COVID-19 and that Pfizer is unable to make recommendations surrounding delaying of the second dose. patient asking if she can't take the 2nd dose until 3 months later from the first dose, is the vaccine still going to be viable, Outcome of the event was unknown.  Information about batch/lot number has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2014, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2015, the patient was treated by a physician for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Mom complained child broke out with itchy rashes first after receiving shot. Then face became swollen. Both nurse and supervisor noted non erythema rash on the face/ though supervisor notified MD via phone. MD stated allergic reaction order Benadryl syrup 1tsp 4-6 hrs.
Two 5 mm and red indurated and fluctuant papular lesions at injection site. Mildly tender. Treated for cellulitis with Cephalexin x 10days.
Pt described red raised erythematous patch on arm inferior to site/area of injection. Pt has no fever or pain. But left arm has patch of raised skin - this appeared about 24 hrs after injection given at pharmacy. Pt will wait and see, if area gets more swollen or pt has temperature his primary MD instructed him to seek further medical attention.
Fever of 100F next day lasted for several hours; Tension headaches; extreme fatigue; lightheadedness; depression lasted for two weeks.; This is a spontaneous report from a non-contactable consumer or other non-health care professional. A 45-years-old non pregnant female patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EL6198), dose 2 via an unspecified route of administration, administered in Arm Right on 10Mar2021 15:45 (Age at vaccination 45 Years) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included multiple allergies, Mild allergies to bactrum, pollen, and some foods. The patient's concomitant medications were not reported. Did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 11Mar 2021 Fever of 100F next day lasted for several hours. Tension headaches, extreme fatigue, light-headedness and depression lasted for two weeks. No treatment received for the adverse events. The outcome for all events was recovering. No follow-up attempts are possible. No further information is expected.
Injection site still extremely painful.  Unable to perform internal/external rotation, lift arm above head.
I got Shingles a little over a year after taking the vaccine. Vaccine doses taken on November 16,2019 and January 22,2020
Itchy bumps on lower arms.  A few days later, itchy bumps persisted along with red patches in the inner elbow areas, hives on arms and neck.
Within an hour of getting vaccine, got an intense migraine headache. . About 2 hours later, developed  chills and fever (as high as 101.5) , achy all over and nauseous. Up all night vomiting . Woke up with severe vertigo,  Room was spinning uncontrollably. Couldn?t even sit up.  It?s been more than 2 months and I still have vertigo.  It is always present, but worse when I sit in a reclining or lying down position.  Other flu like symptoms went away  about 48 hours after the vaccine was administered. The vertigo lingers. Trying any sort of doctor recommended maneuvers makes it much worse and triggers nausea and vomiting.
Rec'd FLUMIST 1/9/14 - mother states developed rash on back, groin, stomach, chest, arms, axilla with itch 2 days after. Resolved after oral antihistamine. No rash since.
Pt rec'd FLUZONE HD in Lt arm and since then has pain in Rt arm and spine.
This is a spontaneous report from a contactable physician. A 53-year-old male patient received his second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number pfel0410) on his left arm, intramuscular on 04Jan2021 14:30 at a single dose for covid-19 immunization. Medical history included hypertension. The patient's concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Dec2020 (first dose). It was reported that about 1 week after 2nd dose, the patient had diffuse edema of face, hands and legs. After edema resolved, skin on fingertips peeled off; all on 11Jan2021. Labs for kidney, liver and thyroid were checked and everything normal. No treatment was received for the events. The outcome of the events was recovered with sequel.
Woke up itching 2/14/2021. I took Benadryl.
Severe low back pain, abdominal cramps, migraines, brain fog, fatigue, pain all over body, pelvic pain, leg pain, muscle spasms, lightheartedness, weakness, fibromyalgia, possible nerve damage, insomnia, light and temperature sensivity, head pain and need for glasses when eyes were good previously, inability to handle loud noise, abnormal menstrual cycles, nausea/vomiting. Weight loss/weight gain/ wrist and finger pain, pudendal nerve entrapment? I have been seeing doctors for two years, been on pain medication, birth control and no certain diagnosis except for fibromyalgia, liver problems.
Got the H1N1 mist on 1/7/10 @ 4 pm, later that night @ around 8:00 pm dad saw some rash spots over body. Gave her an AVEENO bath and BENADRYL woke up 1/8/10 with rash over entire body. Rash are large red circles, some are clustered together.
Information was received from a registered pharmacist referring to an 84 years old patient of unknown gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 26-MAY-2016, the patient received a dose of expired PNEUMOVAX 23 injection (lot # K010523, expired on 25-FEB-2016; dose and route were unknown). No adverse effects were reported. Additional information has been requested.
Fine for a month, then I had a mild respiratory infection and lasted over a day, I thought it was reaction to the smoke, there was forest fires and it was particular bad. I was fine. A week later, it felt like someone was smoking all day, I got home and it smelled like toasted cinnamon. It happens a few days. I saw my doctor approx on 15 Aug - 23Aug2021.  doctors said that give a little time and choose to do MRIs.
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Redness, swelling, tenderness in upper arm reaction on (R) arm - site of PNEUMOVAX flu given in (L) arm.
Administered Novartis H1N1 (4 yrs and older) vaccine 0.25 mL IM right deltoid. Should have given Sanofi Pasteur 0.5mL IM for ages 6 months and older. No signs or symptoms of distress noted.
Beginning  29 August 2021, recurring headaches, body aches, general fatigue. On Saturday, 04 Sep 2021, visited a local site for COVID testing. Both rapid and lab tests were negative for SARS-CoV-2. This outcome was reported by telephone to primary care physician. Because these mild symptoms have persisted, primary care physician  prescribed  treatment of Azithromycin (filled 09/07/2021).
she had to kind of lay down; felt terrible; fever 100.6; Fatigue; right arm was very little short; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (right arm was very little short), MOBILITY DECREASED (she had to kind of lay down), FEELING ABNORMAL (felt terrible), PYREXIA (fever 100.6) and FATIGUE (Fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (right arm was very little short). On 27-Feb-2021, the patient experienced MOBILITY DECREASED (she had to kind of lay down), FEELING ABNORMAL (felt terrible), PYREXIA (fever 100.6) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (right arm was very little short), MOBILITY DECREASED (she had to kind of lay down), FEELING ABNORMAL (felt terrible), PYREXIA (fever 100.6) and FATIGUE (Fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.
This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 19-year-old male patient who received HBV (Engerix B adult) (batch number n4ga4, expiry date 2nd January 2023) for prophylaxis. Co-suspect products included HBV (Engerix B adult) (batch number n4ga4, expiry date 2nd January 2023) for prophylaxis. On 29th September 2021, the patient received Engerix B adult. On 25th August 2021, the patient received Engerix B adult. On 25th August 2021, not applicable after receiving Engerix B adult and unknown after receiving Engerix B adult, the patient experienced inappropriate age at vaccine administration and overdose. On 29th September 2021, the patient experienced inappropriate age at vaccine administration and overdose. On an unknown date, the outcome of the inappropriate age at vaccine administration, overdose, inappropriate age at vaccine administration and overdose were unknown.  Additional details were reported as follows: The reporter reported that a patient of 19 years received two doses of Engerix B adult vaccine, which led to inappropriate age of vaccine administration and overdose. The reporter consented to follow up.
3hr p/vax severe h/a lasting 4-6hr;fever 101-104 lasting 8-10hr;vomiting to hr-poor response to Tigan;hosp for 8hr of IV fluids & was well @ 7AM on 23JUL96;
After receiving the vaccine in the anterolateral portion of the thigh, he developed a circular area of significant erythema (~ 5 x 5 cm) near the site of the injection. This happened soon after administration, while the patient was still in clinic. He was given Benadryl oral x 1 dose and acetaminophen oral x 1 dose, and sent home with a 7-day course of cephalexin for possible local infection. The rash lasted 1-2 weeks and then went away.
1. 11/18/2021 - Outbreak of rash on face diagnosed as shingles on 11/26/2021 by PA at Urgent Care.  No treatment provided as PA said it was more than 72 hours from onset 2. 12/3/2021 - Visit to Dr. - rash developed bacterial infection.  Given Valacyclovir HCL and Cephalexin. 3.  12/26/2021 - Visit to Urgent Care due to new outbreak of rash on back - Diagnosed by PA as shingles.  Given Acylovir 800 mg 4.  1/22/2022 - Tested Positive for COVID 5.  2/3/2022 - Visit to Dr. - New outbreak of rash on opposite side of back - diagnosed as shingles.  Given Valacyclovir HCL 3/9/2022 - Continued issue with lesions on back not healing,.  Biopsy taken
Intended to administer PFIZER BIVALENT BOOSTER, instead administered PFIZER MONOVALENT ADULT gray cap.  Patient on 1/6 stated feeling fine, having tenderness on the arm. Denies anything unusual.
sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left (Lot number: EN6203) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Kidney" (unspecified if ongoing); "Hemoglobin" (unspecified if ongoing); "known allergy: dust pollen any trees" (unspecified if ongoing); "Hypothyroid" (unspecified if ongoing). Concomitant medication(s) included: GLIMEPIRIDE taken for diabetes mellitus; AMLODIPINE taken for blood pressure measurement; OLMESARTAN taken for blood pressure measurement; PREDNISONE [PREDNISONE ACETATE]; SYNTHROID.  The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  Additional information: The patient stated she got the first dose and had no problem just a sore arm.  No follow-up attempts are possible. No further information is expected.
Patient  developed  itchy red  bumps on the  left  arm in the  area  of the  injection  site on 6/5/20  which was  one  day  after  vaccination.  She  presented to the office on  6/8/20 with  persistent  rash localized only to the injection  site.    Mom had  applied  hydrocortisone  without improvement.   Pt was  well beyond  mildly pruritic  rash.  She  was prescribed  fluticasone cream  and  oral  benadryl.
Discharge Provider: MD Primary Care Provider: FNP Admission Date: 9/17/2022 Discharge Date: Sep 18, 2022  PRESENTING PROBLEM: DKA, type 2, not at goal (HCC) [E11.10] Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus (HCC) [E11.10] Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin (HCC) [E11.65, Z79.4] Left lower quadrant abdominal pain [R10.32] COVID-19 [U07.1]   HOSPITAL COURSE: 44 year old male with history of insulin dependant DMII who presented to ER on 9/17/22 with complaints of vomiting. On 9/16/22, patient started with sore throat, cough and SOB. Shortly after, he started with vomiting. Initially, blood sugars were controlled but then started to trend upward despite insulin use. He continued with vomiting overnight and ultimately presented to the ER on 9/17/22. He was found to be in DKA with pH 7.3, anion gap of 25 and bicarb of 12. He was admitted to the ICU, given IV fluids and started on insulin drip. By morning of 9/18/22, anion gap closed and patient was tolerating diet. Blood sugars remained stable on basal bolus insulin and patient is discharged home.   Patient did test positive for COVID on 9/18/22. He did have brief time when oxygen saturations decreased to 88% on room air. He was placed on 2L oxygen but was able to quickly wean back to room air. With drop in oxygen saturations, he was started on oral decardon and IV Remdesivir. By discharge, symptoms are mild and he remains on room air. He was instructed to follow CDC guidelines and remain in isolation for 5 days at home. No medications prescribed at discharge. He can treat symptoms with OTC meds prn.
Patient states that around 22:00 he started to notice that is skin was itching, skin felt hot to the touch, and he had blurry vision. Denies nausea or vomiting, loss consciousness, headache, body aches. Denies taking medication, visiting a doctor or other interventions. Pt states that he did call out of work the next day. States that symptoms lasted the rest of the night but were gone by the next day. Denies symptoms after first vaccine in the series given 28JUNE2023.
No symptoms. Tested positive for COVID after high risk exposure on 2/22/2021 after being fully vaccinated. Narrative: Tested positive for COVID after high risk exposure on 2/22/202 after being fully vaccinated. Still under quarantine
The first two doses, i had normal symptoms that lasted only 1-3 days (headache, fatigue, sore arm, etc.) After the booster, i only had a sore arm for 3 days. Now, 11 days after receiving the booster,  i broke out in the most insane full body hives and rashes. They are so inflamed, spreading constantly on every inch of my body. They are extremely hot to the touch.
Patient was given pediatric/adolescent Hep B vaccine for the adult strength Hep B vaccine.  Patient experienced no problems and was revaccinated with the correct vaccine ASAP.  She will continue with series per protocol.
24JUN91 felt warmer than usual by 5PM, then @ 1130PM became irritable & started vomiting & vomiting continues this AM; No problems w/previous immun; Seen in ER 24JUN91 felt was vax rxn;
Patient reported having rash/itching (generalized); tingling to arms and legs, a little tightness to throat. Symptoms started few minutes after vaccination. Patient seen by EMS and was observed for about 30 minutes. Symptoms worsened and EMS administered IV Benadryl. Patient was transported to ER.
Horrible, throbbing head-ache (felt like my head was going to explode) I had the same head-ache issues after the first 2 injections, but did not realize that they were caused by the Covid shots until I experienced the same symptoms after this  booster shot
ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM 8/12/2022 &  10/8/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
She went on to develop severe covid in Early August and ended up hospitalized in on a vent.  She did survive without known  sequellae at this point.
Pharmacist unwilling pulled vaccine from package with a past beyond use date. Vaccine was administered to the patient 3 days past beyond use date of 7/29/2022 lot 016b22a expire date 11/13/2022 beyond use date of 07/29/2022
INJECTION SITE REACTION. THE AREA IS RED, SWOLLEN, HOT AND HAS STRIKING.
Patient had upper arm pain that caused her to seek medical attention. Patient waited 4 weeks and arm was still sore so she went to MD on 11-5-10.